Informations juridiques
How to Choose the Right Personal Injury Attorney in NY: 3 Key Factors
Choosing the right personal injury attorney in NY determines whether you recover full compensation or settle for less. Discover three factors every New York injury victim must evaluate before hiring. The right personal injury attorney in NY is not simply the one with the loudest advertisement, it is the one who understands New York's specific procedural rules, knows how local courts operate, and communicates with you honestly from day one. I always tell clients: ask hard questions during that first consultation, because how a personal injury attorney responds in that meeting tells you everything about how they will handle your case. Your choice of attorney is, without question, one of the most consequential decisions you will make after an injury.
Lire la suite
Divorce Waiting Periods: State Requirements & Timeline Guide
A divorce waiting period requires spouses to wait a mandatory period between filing and finalization. State statutes determine cooling-off durations, which range from zero days in New York to several months elsewhere.
Lire la suite
Marriage-Based Visa Eligibility: Who Qualifies and What You Need
Learn who qualifies for marriage-based visa eligibility, which supporting documents strengthen an application, and how to prepare before filing for permanent residence. Marriage-based visa eligibility begins with proving that the marriage is legally valid and was entered into in good faith under U.S. .mmigration law. Marriage-based visa eligibility also requires a qualifying U.S. .itizen or lawful permanent resident petitioner together with complete civil, financial, and relationship documentation. From my experience, reviewing marriage-based visa eligibility before filing often helps applicants identify missing evidence and resolve potential legal issues before they delay the case.
Lire la suite
Foreign Tax Credit Claims for Dividend and Royalty Withholding Tax
A domestic corporation that pays foreign withholding tax on dividends or royalties may claim a direct credit under 26 U.S.C. § 901, reported on Form 1118. Two things determine whether the credit is actually available. The first is whether the foreign tax is creditable at all. The 2022 final regulations narrowed that definition, and a number of foreign withholding taxes on royalties — along with most digital services taxes — ceased to qualify. Notice 2023-55 allowed taxpayers to apply the prior rules for 2022 and 2023, and proposed regulations added an exception for royalties paid under a single-country license: one that designates the payments as royalties and limits the licensed territory to the taxing country, or a multi-country agreement that separately states the amount attributable to that country. Those regulations remain proposed, so the position for a current year should be confirmed before filing. The practical consequence is that dividend withholding and royalty withholding do not behave the same way, and how the license is drafted can decide the credit. The second is the limitation under § 904. The credit cannot exceed the US tax on foreign-source income, computed separately for the passive, general, GILTI, and foreign branch categories, so whether a royalty falls in the passive or general basket changes the result. Unused credits carry back one year and forward ten — except in the GILTI basket, where they cannot be carried at all. Where a treaty reduces the withholding rate, claiming that reduction at source is usually preferable to paying the full rate and seeking a credit that may be limited or non-creditable.
Lire la suite
Fdi Clearance Approval Process for Foreign Investment Control in Us
FDI clearance governs CFIUS review, filing triggers, timelines, mitigation terms, and foreign investment approval risks. FDI clearance is the regulatory process used to assess foreign investments that may affect U.S. .ational security, critical infrastructure, or sensitive technologies. Understanding FDI clearance requires more than identifying filing thresholds; investors should evaluate CFIUS jurisdiction, ownership structures, control rights, review procedures, mitigation agreements, enforcement risks, and transaction timing. Proper FDI clearance planning helps reduce divestment risk, avoid penalties, and improve deal certainty in cross-border investments.
Lire la suite
How Can a Pharmaceutical Patent Protect New Drug Innovation?
A pharmaceutical patent is a form of intellectual property protection that grants a patent holder exclusive rights to manufacture, use, sell, and distribute a new drug or therapeutic compound for a defined period, typically twenty years from the filing date. Patent law operates under a strict procedural framework where the United States Patent and Trademark Office (USPTO) examines applications against statutory requirements of novelty, non-obviousness, and utility. Failure to meet procedural deadlines, inadequate disclosure of the invention, or prior art references can result in patent rejection or invalidity challenges that strip away protection entirely. This article covers how pharmaceutical patents function, the examination process, enforcement mechanisms, and the strategic considerations healthcare professionals and industry stakeholders should understand when navigating patent landscapes in drug development and commercialization.
Lire la suite
